Ameriprise
SGNT

Ameriprise’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Ameriprise’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-432,937
Closed -$6.49M – 3903
2016
Q2 		$6.49M Buy
432,937
+320,800
+286% +$4.12M ﹤0.01% 1746
2016
Q1 		$1.36M Buy
112,137
+2,078
+2% +$29.1K ﹤0.01% 2713
2015
Q4 		$1.75M Sell
110,059
-2,193
-2% -$34.5K ﹤0.01% 2674
2015
Q3 		$1.72M Buy
112,252
+5,077
+5% +$110K ﹤0.01% 2698
2015
Q2 		$2.6M Buy
107,175
+1,917
+2% +$45.9K ﹤0.01% 2578
2015
Q1 		$2.45M Buy
105,258
+5,094
+5% +$135K ﹤0.01% 2486
2014
Q4 		$2.52M Buy
100,164
+1,494
+2% +$43.8K ﹤0.01% 2452
2014
Q3 		$3.07M Buy
+98,670
New +$2.67M ﹤0.01% 2315
2013
Q4 		– Sell
-1,040
Closed -$21K – 5639
2013
Q3 		$21K Hold
1,040
– – ﹤0.01% 4392
2013
Q2 		$22K Buy
+1,040
New +$18.6K ﹤0.01% 4222

Ameriprise's SGNT Position: Q3 2016 in Review

Ameriprise sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 432,937 shares — an estimated $6.49M sold.

Ameriprise first reported a position in SGNT in Q2 2013 and held it in 10 quarters. The position peaked at $6.49M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Ameriprise reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Ameriprise sold 432,937 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $6.49M.
  • Ameriprise first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 10 quarters.
  • Ameriprise's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $6.49M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Ameriprise's 13F filing for Q3 2016, filed 8 Nov 2016.